ICC/IF analysis of HeLa cells using GTX87998 TRA-2 alpha antibody. The picture on the right is blocked with the synthesized peptide.
ICC/IF analysis of HeLa cells using GTX87998 TRA-2 alpha antibody. The picture on the right is blocked with the synthesized peptide.
TRA-2 alpha antibody
GTX87998
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetTRA2A
Overview
- SupplierGeneTex
- Product NameTRA-2 alpha antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500~1:1000. ICC/IF: 1:100~1:500. IHC-P: 1:50~1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID29896
- Target nameTRA2A
- Target descriptiontransformer 2 alpha homolog
- Target synonymsAWMS1; HSU53209; htra-2 alpha; putative MAPK activating protein PM24; TRA-2 alpha; Tra2alpha; TRA2-alpha; transformer-2 alpha; transformer-2 protein homolog A; transformer-2 protein homolog alpha
- HostRabbit
- IsotypeIgG
- Protein IDQ13595
- Protein NameTransformer-2 protein homolog alpha
- Scientific DescriptionThis gene is a member of the transformer 2 homolog family and encodes a protein with several RRM (RNA recognition motif) domains. This phosphorylated nuclear protein binds to specific RNA sequences and plays a role in the regulation of pre-mRNA splicing. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2013]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Differential Degradation of TRA2A and PYCR2 Mediated by Ubiquitin E3 Ligase E4B. Lu Y et al., 2022, Front Cell Dev BiolRead more
- Human TRA2A determines influenza A virus host adaptation by regulating viral mRNA splicing. Zhu Y et al., 2020 Jun, Sci AdvRead more
- TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing. Liu T et al., 2017 Jul, Mol Cancer TherRead more